Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
Abstract To investigate associations between isoniazid for latent tuberculosis and risk of severe hepatitis, affecting patients with rheumatoid arthritis or ankylosing spondylitis whose treatment includes tumor necrosis factor inhibitors. Our self-controlled case series study analyzed Taiwan’s Natio...
Guardado en:
Autores principales: | Edward Chia-Cheng Lai, Hsun-Yin Liang, Ya-Chun Huang, Wei-I. Huang, Pi-Hui Chao, Wen-Wen Chen, Meng-Yu Weng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/82795d18c5e8488db3f4a6b9e7e8ad68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
por: Lin HS, et al.
Publicado: (2016) -
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
por: Heng Yang, et al.
Publicado: (2021) -
Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
por: M Pourhajibagher, et al.
Publicado: (2012) -
Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis under TNFα inhibitors: a 24-month prospective study
por: Carina M. F. Gomes, et al.
Publicado: (2021) -
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid
por: Yuhan Jiang, et al.
Publicado: (2021)